Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · Available online 25 Jun 2026 · In press · DOI 10.1177/1540658x261438871

Authors (2)

Ningning Xie, Yahan Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Xie, N., Zhang, Y. (2026). Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES. https://doi.org/10.1177/1540658x261438871

Related articles

• Identification of Selective Small Molecule Modulators of mRNA Processing Using a Multiplexed QuantiGene High-Throughput Screening Platform · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Precision Targeting in Gastric Cancer: AI-Driven Discovery of MET, ADORA2A, CDK5R1, and ADORA1 · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Decoding Cholesterol Metabolic Regulation by Naotai Formula in Stroke Management: An Integrated Network Pharmacology and Mendelian Randomization Approach · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Letter: New Horizons in Biomarker Discovery: Assay Technologies for Personalized Drug Development · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Advances in Capsaicin-Based Nanocarriers: Bridging Mechanistic Insights with Therapeutic Potential and Clinical Outcomes · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Elucidating Genetic and Immunological Pathways Mediated by Sodium-Glucose Transporter 2 Inhibitors in Reducing Gout Risk: A Two-Step Mendelian Randomization Study · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Ultrafast Detection of Environmental Pollutants and Pharmaceutical Residues Using a CuFe Nanozyme-Enhanced Sensing Platform · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal